Clinical Trials Browser

Phase 3 × Breast Neoplasms × Celecoxib × Clear all

NCT02429427 2020-06-23

REACT

Phase 3 Completed

2,639 enrolled 12 charts

Breast Neoplasms

NCT00525096 2011-06-30

Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms